A New Marker for Early Diagnosis of Pneumoperitoneum-Related Acute Kidney Injury: Insulin-Like Growth Factor-1 (IGF-1)

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

February 8, 2023

Primary Completion Date

March 30, 2023

Study Completion Date

May 30, 2023

Conditions
Acute Kidney Injury (Nontraumatic)Pneumoperitoneum
Interventions
DIAGNOSTIC_TEST

IGF-1

We need to diagnose acute kidney injury in the early postoperative period. The markers examined so far do not provide enough information to diagnose acute kidney injury early. For this reason, many different biomarkers are used in the early diagnosis of acute kidney injury in many parts of the world. Thanks to our research, we can recognise the development of acute kidney injury at an early stage and determine whether a previously unused biomarker (IGF-1) is effective in the early diagnosis of acute kidney injury.

Trial Locations (1)

06560

Çağla Yazar, MD, Ankara

All Listed Sponsors
lead

Baskent University

OTHER